等待開盤 07-17 09:30:00 美东时间
-0.150
-1.32%
多家机构首予Amrize买入评级,目标价53~62美元;HC Wainwright & Co.上调内克塔治疗目标价至120美元,维持"买入"评级>>
06-25 08:39
Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and lowers the price target from $15 to $13.
06-24 23:26
Goldman Sachs analyst Matthew Sykes upgrades Sotera Health (NASDAQ:SHC) from Neutral to Buy and raises the price target from $14 to $17.
05-05 17:09
Companies Reporting Before The Bell • Itron (NASDAQ:ITRI) is projected to repor...
05-01 16:32
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1122473387096023041.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler:维持Devon Energy(DVN)"超配"评级,目标价从54美元升至56美元</p> <p>• Piper Sandler:维持Home Bancorp(HBCP)"超配"评级,目标价从60
04-25 10:28
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1122085978711785472.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler:维持Devon Energy(DVN)"超配"评级,目标价从54美元升至56美元</p> <p>• HC Wainwright & Co.:上调Dogwood Therapeutics(
04-24 09:56
CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SH...
04-18 05:16
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117373634651086848.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity:维持Travere Therapeutics(TVTX)"买入"评级,目标价从45美元升至47美元</p> <p>• JMP证券:维持Benitec生物制药(BNTC)"跑赢大市"评级,
04-11 09:36
Sotera Health ( ($SHC) ) has provided an update. On April 3, 2025, Sterigenics ...
04-04 19:59
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1102515815739830272.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Denali Therapeutics(DNLI)"买入"评级,目标价从80美元升至87美元</p> <p>• HC Wainwright & Co.:维持Car
03-01 09:21